Blockade of human IsK channels expressed in Xenopus oocytes by the novel class III antiarrhythmic NE-10064. 1994

A E Busch, and T Herzer, and T Takumi, and P Krippeit-Drews, and S Waldegger, and F Lang
Physiologisches Institut I, Eberhard-Karls-Universität Tübingen, Germany.

cRNA encoding the human IsK protein was injected into Xenopus oocytes and the expressed channels were investigated using the two-microelectrode voltage-clamp method. The novel class III antiarrhythmic NE-10064 (1-[[[5-(4-chlorophenyl)-2-furanyl]methylene]-amino]-3- [4-(4-methyl-1-piperazinyl)-butyl]-2,4-imidazolidinedione dihydrochloride) was tested for its ability to block these channels. The compound displayed potent inhibitory effects with an EC50 of 5.4 microM. The block caused by NE-10064 was use-dependent, i.e. channels had to be activated for the inhibition to occur. Further, the reversal of the inhibition during the wash-out period was use-dependent. Finally, the blockade of human IsK channels by NE-10064 appeared to be voltage-dependent, being more pronounced at depolarized potentials. We conclude that this novel class III antiarrhythmic is a potent inhibitor of human IsK channels and suggest that such effects could be involved in its antiarrhythmic action.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008564 Membrane Potentials The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization). Resting Potentials,Transmembrane Potentials,Delta Psi,Resting Membrane Potential,Transmembrane Electrical Potential Difference,Transmembrane Potential Difference,Difference, Transmembrane Potential,Differences, Transmembrane Potential,Membrane Potential,Membrane Potential, Resting,Membrane Potentials, Resting,Potential Difference, Transmembrane,Potential Differences, Transmembrane,Potential, Membrane,Potential, Resting,Potential, Transmembrane,Potentials, Membrane,Potentials, Resting,Potentials, Transmembrane,Resting Membrane Potentials,Resting Potential,Transmembrane Potential,Transmembrane Potential Differences
D008839 Microelectrodes Electrodes with an extremely small tip, used in a voltage clamp or other apparatus to stimulate or record bioelectric potentials of single cells intracellularly or extracellularly. (Dorland, 28th ed) Electrodes, Miniaturized,Electrode, Miniaturized,Microelectrode,Miniaturized Electrode,Miniaturized Electrodes
D009865 Oocytes Female germ cells derived from OOGONIA and termed OOCYTES when they enter MEIOSIS. The primary oocytes begin meiosis but are arrested at the diplotene state until OVULATION at PUBERTY to give rise to haploid secondary oocytes or ova (OVUM). Ovocytes,Oocyte,Ovocyte
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D005260 Female Females
D006827 Hydantoins Compounds based on imidazolidine dione. Some derivatives are ANTICONVULSANTS. Hydantoin,Imidazolidine-2,4-Diones,Imidazolidine 2,4 Diones
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

A E Busch, and T Herzer, and T Takumi, and P Krippeit-Drews, and S Waldegger, and F Lang
July 1994, Biochemical and biophysical research communications,
A E Busch, and T Herzer, and T Takumi, and P Krippeit-Drews, and S Waldegger, and F Lang
December 1992, British journal of pharmacology,
A E Busch, and T Herzer, and T Takumi, and P Krippeit-Drews, and S Waldegger, and F Lang
June 1999, Pflugers Archiv : European journal of physiology,
A E Busch, and T Herzer, and T Takumi, and P Krippeit-Drews, and S Waldegger, and F Lang
January 1998, Proceedings of the Western Pharmacology Society,
A E Busch, and T Herzer, and T Takumi, and P Krippeit-Drews, and S Waldegger, and F Lang
January 2001, Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994),
A E Busch, and T Herzer, and T Takumi, and P Krippeit-Drews, and S Waldegger, and F Lang
August 2014, Neuroscience bulletin,
A E Busch, and T Herzer, and T Takumi, and P Krippeit-Drews, and S Waldegger, and F Lang
April 1999, Biophysical journal,
A E Busch, and T Herzer, and T Takumi, and P Krippeit-Drews, and S Waldegger, and F Lang
March 1990, The American journal of physiology,
A E Busch, and T Herzer, and T Takumi, and P Krippeit-Drews, and S Waldegger, and F Lang
December 1993, Journal of cardiovascular pharmacology,
A E Busch, and T Herzer, and T Takumi, and P Krippeit-Drews, and S Waldegger, and F Lang
January 1998, British journal of pharmacology,
Copied contents to your clipboard!